MedPage Today June 14, 2024
— Anti-abortion states continue to fight; a possible Trump victory opens door to new strategies
In the wake of the Supreme Court’s decision to preserve access to mifepristone (Mifeprex) on Thursday, abortion-rights groups worry the threat has not passed while anti-abortion groups agree they’re not done fighting against the drug.
In FDA v. the Alliance for Hippocratic Medicine, the justices ruled that the plaintiffs — a group of anti-abortion doctors who sued over the drug’s approval — lacked the right to sue because they couldn’t demonstrate that the FDA’s approval and subsequent actions to remove barriers to accessing the drug actually harmed them.
“The bottom line is that these attacks on medication abortion and on all abortions nationwide are absolutely...
Today's Sponsors
Today's Sponsor